Confirmed by sequence analysis, this non-synonymous substitution affects an amino acid residue located within a WD40 domain repeat of the EML5 protein and corresponds to a human EML5 mutation associated with cancer (Wellcome Sanger Institute). The gene discussed is EML5; the disease is cancer.